Publications en collaboration avec des chercheurs de Lebanese University (11)

2023

  1. Characterization of Leishmania Parasites Isolated from Naturally Infected Mammals

    Animals, Vol. 13, Núm. 13

  2. Mixed micelles and gels of a hydrophilic poloxamine (Tetronic 1307) and miltefosine: Structural characterization by small-angle neutron scattering and in vitro evaluation for the treatment of leishmaniasis

    Journal of Molecular Liquids, Vol. 379

  3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. Correction to: A rapid and low‑cost protocol for the detection of B.1.1.7 lineage of SARS‑CoV‑2 by using SYBR Green‑based RT‑qPCR (Molecular Biology Reports, (2021), 48, 11, (7243-7249), 10.1007/s11033-021-06717-y)

    Molecular Biology Reports

  2. Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

    Pharmaceutics, Vol. 14, Núm. 11

2021

  1. A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR

    Molecular Biology Reports, Vol. 48, Núm. 11, pp. 7243-7249

  2. Activity of anti-microbial peptides (Amps) against leishmania and other parasites: An overview

    Biomolecules, Vol. 11, Núm. 7

  3. An antibiotic potentiator retains its activity after being immobilized on silicone and prevents growth of multidrug-resistant Pseudomonas aeruginosa biofilms

    Materials Science and Engineering C, Vol. 121

2020

  1. A synthetic peptide sensitizes multi-drug resistant Pseudomonas aeruginosa to antibiotics for more than two hours and permeabilizes its envelope for twenty hours

    Journal of Biomedical Science, Vol. 27, Núm. 1

2019

  1. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains

    Scientific Reports, Vol. 9, Núm. 1

  2. AMPs as anti-biofilm agents for human therapy and prophylaxis

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 257-279